Working… Menu

Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03728829
Recruitment Status : Recruiting
First Posted : November 2, 2018
Last Update Posted : July 9, 2021
Information provided by (Responsible Party):
Liu Yunjiang, Hebei Medical University Fourth Hospital

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 30, 2022
Estimated Study Completion Date : December 31, 2022